
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Crossroads Health Ventures is a venture capital firm established to foster innovation within the life sciences sector. Founded in Indianapolis, Indiana, the firm is dedicated to supporting early-stage companies that align with the interests of its strategic limited partners. The organization focuses on U.S.-based startups, ensuring that its investments are closely tied to the evolving needs of the healthcare landscape.
As a firm, Crossroads Health Ventures emphasizes collaboration with its limited partners, which include various stakeholders in the life sciences industry. This alignment allows the firm to leverage insights and resources that can significantly benefit its portfolio companies. The firm operates from its headquarters in Indianapolis, a city known for its growing life sciences ecosystem.
Crossroads Health Ventures concentrates its investments on the life sciences sector, specifically targeting early-stage companies. The firm is active in various funding stages, including Pre-seed, Seed, Seed+ (Extension), Series A, and Series A+ (Extension). This range allows them to support startups at critical junctures in their development.
The organization seeks to invest in companies that demonstrate innovative approaches to healthcare challenges. By aligning with strategic limited partners, Crossroads Health Ventures ensures that its investments not only provide financial backing but also access to valuable industry expertise and networks.
Samantha Ginther, MPH - Principal. Samantha has a background in public health and brings expertise in healthcare innovation.
Emily Atkinson, PhD - Senior Director of Innovation, BioCrossroads. Emily has a strong academic background and experience in driving innovation in the life sciences.
Ting Gootee, CFA, CAIA - EVP Digital Adoption at CICP and Managing Director. Ting specializes in digital adoption strategies within the life sciences sector.
Chelsea Linder - VP of Innovation & Entrepreneurship, TechPoint. Chelsea focuses on fostering innovation and entrepreneurship in technology and life sciences.
Vince Wong, JD, MBA - Managing Director. Vince has a legal and business background, providing insights into regulatory and operational aspects of startups.
Christy Wright - President & CEO, AgriNovus Indiana. Christy leads initiatives in agriculture and life sciences, contributing to the firm’s strategic direction.
To pitch to Crossroads Health Ventures, founders should use the inquiry form available on their website at Crossroads Health Ventures Pitch Form. It is important to include comprehensive details about the startup, including the team, product, market opportunity, and alignment with the firm’s focus on life sciences.
Response times may vary, so founders should be prepared for potential follow-up discussions or requests for additional information.
What stages does Crossroads Health Ventures invest in?
Crossroads Health Ventures invests in Pre-seed, Seed, Seed+ (Extension), Series A, and Series A+ (Extension) stages, focusing on early-stage companies.
What sectors does Crossroads Health Ventures focus on?
The firm primarily invests in the life sciences sector, with a specific emphasis on biotech and healthcare innovations.
How can I pitch my startup to Crossroads Health Ventures?
Founders can pitch their startups through the inquiry form available on their website at Crossroads Health Ventures Pitch Form. It is advisable to provide detailed information about your business model, market potential, and alignment with their investment focus.
What makes Crossroads Health Ventures different from other investors?
Crossroads Health Ventures emphasizes alignment with strategic limited partners, which enhances their ability to provide not just capital but also industry insights and connections that can be crucial for early-stage companies.
What is the geographic focus of Crossroads Health Ventures?
The firm focuses exclusively on early-stage companies based in the United States, ensuring that they are well-versed in the local market dynamics and regulatory environment.
What kind of support can portfolio companies expect?
While specific details about post-investment support are not disclosed, the firm’s alignment with strategic partners suggests that portfolio companies may benefit from mentorship, industry connections, and operational guidance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.